These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17604418)

  • 1. Signal detection in the pharmaceutical industry: integrating clinical and computational approaches.
    Hauben M
    Drug Saf; 2007; 30(7):627-30. PubMed ID: 17604418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of data mining in pharmacovigilance.
    Hauben M; Madigan D; Gerrits CM; Walsh L; Van Puijenbroek EP
    Expert Opin Drug Saf; 2005 Sep; 4(5):929-48. PubMed ID: 16111454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential use of data-mining algorithms for the detection of 'surprise' adverse drug reactions.
    Hauben M; Horn S; Reich L
    Drug Saf; 2007; 30(2):143-55. PubMed ID: 17253879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decision support methods for the detection of adverse events in post-marketing data.
    Hauben M; Bate A
    Drug Discov Today; 2009 Apr; 14(7-8):343-57. PubMed ID: 19187799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Principles of data mining.
    Hand DJ
    Drug Saf; 2007; 30(7):621-2. PubMed ID: 17604416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety related drug-labelling changes: findings from two data mining algorithms.
    Hauben M; Reich L
    Drug Saf; 2004; 27(10):735-44. PubMed ID: 15350157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database.
    Szarfman A; Machado SG; O'Neill RT
    Drug Saf; 2002; 25(6):381-92. PubMed ID: 12071774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of triage strategies in the WHO signal-detection process.
    Lindquist M
    Drug Saf; 2007; 30(7):635-7. PubMed ID: 17604420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endotoxin-like reactions with intravenous gentamicin: results from pharmacovigilance tools under investigation.
    Hauben M; Reich L
    Infect Control Hosp Epidemiol; 2005 Apr; 26(4):391-4. PubMed ID: 15865275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmarketing surveillance of potentially fatal reactions to oncology drugs: potential utility of two signal-detection algorithms.
    Hauben M; Reich L; Chung S
    Eur J Clin Pharmacol; 2004 Dec; 60(10):747-50. PubMed ID: 15619136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Criteria revision and performance comparison of three methods of signal detection applied to the spontaneous reporting database of a pharmaceutical manufacturer.
    Matsushita Y; Kuroda Y; Niwa S; Sonehara S; Hamada C; Yoshimura I
    Drug Saf; 2007; 30(8):715-26. PubMed ID: 17696584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A brief primer on automated signal detection.
    Hauben M
    Ann Pharmacother; 2003; 37(7-8):1117-23. PubMed ID: 12841826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reports of hyperkalemia after publication of RALES--a pharmacovigilance study.
    Hauben M; Reich L; Gerrits CM
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):775-83. PubMed ID: 16804951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Illusions of objectivity and a recommendation for reporting data mining results.
    Hauben M; Reich L; Gerrits CM; Younus M
    Eur J Clin Pharmacol; 2007 May; 63(5):517-21. PubMed ID: 17364192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of consumer reporting on signal detection: using disproportionality analysis.
    Hammond IW; Rich DS; Gibbs TG
    Expert Opin Drug Saf; 2007 Nov; 6(6):705-12. PubMed ID: 17967159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innovations for the future of pharmacovigilance.
    Almenoff JS
    Drug Saf; 2007; 30(7):631-3. PubMed ID: 17604419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving paradigms in pharmacovigilance.
    Brewster W; Gibbs T; Lacroix K; Murray A; Tydeman M; Almenoff J
    Curr Drug Saf; 2006 May; 1(2):127-34. PubMed ID: 18690923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of statistical signal detection methods within and across spontaneous reporting databases.
    Candore G; Juhlin K; Manlik K; Thakrar B; Quarcoo N; Seabroke S; Wisniewski A; Slattery J
    Drug Saf; 2015 Jun; 38(6):577-87. PubMed ID: 25899605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives on the use of data mining in pharmaco-vigilance.
    Almenoff J; Tonning JM; Gould AL; Szarfman A; Hauben M; Ouellet-Hellstrom R; Ball R; Hornbuckle K; Walsh L; Yee C; Sacks ST; Yuen N; Patadia V; Blum M; Johnston M; Gerrits C; Seifert H; Lacroix K
    Drug Saf; 2005; 28(11):981-1007. PubMed ID: 16231953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal detection: historical background.
    Egberts TC
    Drug Saf; 2007; 30(7):607-9. PubMed ID: 17604412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.